0001127602-18-036571.txt : 20181218
0001127602-18-036571.hdr.sgml : 20181218
20181218162210
ACCESSION NUMBER: 0001127602-18-036571
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181214
FILED AS OF DATE: 20181218
DATE AS OF CHANGE: 20181218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: APPIO THOMAS
CENTRAL INDEX KEY: 0001683323
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 181240777
MAIL ADDRESS:
STREET 1: 400 SOMERSET CORPORATE BOULEVARD
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bausch Health Companies Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
FORMER COMPANY:
FORMER CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
DATE OF NAME CHANGE: 20100928
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2018-12-14
0000885590
Bausch Health Companies Inc.
BHC
0001683323
APPIO THOMAS
400 SOMERSET CORPORATE BOULEVARD
BRIDGEWATER
NJ
08807
1
Pres&Co-Head Bausch&Lomb/Int'l
Common Stock, No Par Value
2018-12-14
4
P
0
25440
22.9567
A
128922
D
Common Stock, No Par Value
2018-12-14
4
A
0
25440
0
A
154362
D
The price in Column 4 is a weighted average price. The prices actually paid in this transaction are within the range of $22.94 to $22.96 per share. Upon request by the Commission staff, the Issuer or the reporting person will provide full information regarding the number of Common Shares purchased by the reporting person at each separate price within the range set forth in this footnote.
Represents matching Restricted Share Units ("MRSUs") granted to the Reporting Person in connection with the open market purchase of Common Shares of the Issuer reported above (the "Purchased Shares"), pursuant to the Issuer's Matching Share Program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant ("MRSU Grant Date"), subject to the Reporting Person's continued service (except in limited circumstances).
/s/ Kirsten O'Donnell, attorney-in-fact for Thomas Appio
2018-12-18